Boxin (Shenzhen) R&D Headquarters: Located in Nanshan Zhiyuan (Nanshan District Life Science and Technology Industrial Park) Technology and Projects ★2D-3D SZC primary culture and drug screening technology ★3D printing PDX animal drug screening technology ★Single cell + spatial transcriptome technology ★Organoid and single-cell drug susceptibility testing technology ★Specific healthy human allogeneic DC-CIK cell tumor therapy   Boxin (Hong Kong) R&D Headquarters: Located in Hong Kong Science Park (HKSP) ★Precision medicine for cancer ★Mesenchymal stem cell exosomes ★Mesenchymal stem cell lysate ★Stem Cell Serum ★Scalp stem cell growth liquid ★Stem Cell Mask ★Whole Fetal Serum ★Nerve growth factor

The team currently has 39 members (including Shenzhen and Hong Kong teams), including 17 with doctoral and post-doctoral research backgrounds, 11 with master's degrees, 9 with post-doctoral degrees, and 11 with doctoral degrees; including 1 outstanding young medical talent in Guangdong Province, Shenzhen overseas There are 6 high-level talents. He has presided over and participated in more than 50 scientific research projects at all levels, including 15 projects of the National Natural Science Foundation of China, nearly 20 other provincial and ministerial projects, and more than 40 million scientific research funds. Recently, team members have published a total of 61 papers as the first or corresponding author in high-level journals such as Molecular Cancer, Journal of Experimental Medicine, Signal Transduction and Targeted Therapy, Journal of Thoracic Oncology, Autophagy, Pharmacology & Therapeutics, among which the impact factor is very high. The above 14 articles, of which 3 articles are above 20 points. More than 20 patents have been applied and more than 10 patents have been authorized.